Novel Approaches to Target the Immune System in Gastrointestinal Cancers PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Novel Approaches to Target the Immune System in Gastrointestinal Cancers PDF full book. Access full book title Novel Approaches to Target the Immune System in Gastrointestinal Cancers by Gianluigi Giannelli. Download full books in PDF and EPUB format.
Author: David Kerr Publisher: Springer ISBN: 3319430637 Category : Medical Languages : en Pages : 252
Book Description
This book is about the manipulation of the immune system as a therapeutic approach to gastrointestinal cancer and its clinical applications, exploring therapeutic approaches which might be taken under the broad banner of immunotherapy. Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based treatment; antibody therapy; cytokine application and the key effector cells and mechanisms which might cause tumour rejection. The reverse side of this equation, the genetic and molecular mechanisms which the tumour can use to escape immune control and regulation, is also discussed. Through reviewing the most up-to-date evidence, this volume provides an overview of the important scientific lessons learned from past failure of immunotherapeutics in the clinic and highlights more positive recent data, coupled to practical guidelines for clinical usage. Written by a team of worldwide experts, this is an indispensable guide for medical oncologists, surgical oncologists, radiation therapists, pharmacists, oncology nurse specialists.
Author: Ganji Purnachandra Nagaraju Publisher: Springer Nature ISBN: 9811554714 Category : Medical Languages : en Pages : 259
Book Description
This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.
Author: Patrick H. Lizotte Publisher: ISBN: Category : Languages : en Pages : 236
Book Description
Many kinds of cancer, and almost universally metastatic cancer, are refractory to treatment by conventional methods: surgery radiation, and non-specific cytotoxic chemotherapy. The dawn of the age of personalized medicine presaged 15 years ago with the completion of the human genome project has thus far largely failed to deliver on the promise of targeted therapeutics. We have recently seen the development of immunotherapy as a compliment to these methods. Immunotherapies hold an advantage in that they are not specific to driver mutations or oncogenic pathways that may change, but recognize an array of tumors antigens and can adapt over time to the emergence of new tumor cell populations with new characteristic mutations and antigens. In order to achieve systemic long-lasting anti-tumor immunity, immunosuppression in the tumor microenvironment must be overcome. We have developed technologies to accomplish this through the targeting and activation of immunosuppressive innate leukocytes that without treatment would otherwise promote tumor survival, growth, and metastasis, and inhibit the establishment of tumor-specific immunity. We have utilized an attenuated strain of Listeria monocytogenes and the self-assembling eCPMV viral-like nanoparticle. These two immunotherapies target innate leukocytes in the tumor microenvironment and induce their production of pro-inflammatory cytokines and chemokines that recruit in new effector cell subsets. Listeria and eCPMV show clear efficacy in mouse models of melanoma, ovarian carcinoma, colon cancer, and breast carcinoma. Our results highlight the value in emerging therapeutic strategies that target immunosuppressive innate immune cells in the tumor microenvironment.
Author: National Research Council Publisher: National Academies Press ISBN: 0309180686 Category : Medical Languages : en Pages : 102
Book Description
Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.
Author: Kenneth Murphy Publisher: Garland Science ISBN: 9780815344575 Category : Medical Languages : en Pages :
Book Description
The Janeway's Immunobiology CD-ROM, Immunobiology Interactive, is included with each book, and can be purchased separately. It contains animations and videos with voiceover narration, as well as the figures from the text for presentation purposes.
Author: Marnix Jansen Publisher: Springer ISBN: 3319413880 Category : Medical Languages : en Pages : 486
Book Description
This book is a comprehensive understanding of the evolution of pre-malignant disease, emphasizing common themes in the field, including stem cell biology and histologic modes of cancer progression between the distal esophagus and stomach. Its sixteen chapters discuss metaplastic tissue change in the upper GI, clonalexpansion of early neoplasia, stem cell dynamics in experimental models, pathology of early esophageal squamous cell carcinoma, therapeutic modalities for esophageal squamous cell carcinoma, pathology of Barrett’s esophagus, screening, early detection and novel diagnostic tools for Barrett's esophagus, clonal evolution of Barrett’s esophagus, endoscopic therapeutic modalities of early esophageal cancer, pathology of early gastric cancer, and experimental models for gastric cancer. Stem Cells, Pre-neoplasia and Early Cancer of the Upper Gastrointestinal Tract is an integrative text on both the current state of translational research on every cancer development of the upper gastrointestinal tract as well as on novel clinical diagnostic and therapeutic modalities. It highlights a rapidly growing field within cancer research and is essential reading for oncologists, biochemists and advanced graduate students alike. Springer’s Advances in Experimental Medicine and Biology series presents multidisciplinary and dynamic findings in the broad fields of experimental medicine and biology. The wide variety in topics it presents offers readers multiple perspectives on a variety of disciplines including neuroscience, microbiology, immunology, biochemistry, biomedical engineering and cancer research.
Author: Vamsidhar Velcheti Publisher: Elsevier Health Sciences ISBN: 032367299X Category : Medical Languages : en Pages : 355
Book Description
Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies.